Search results for: germany

The EU Pharmaceutical package missed the mark in t...

EFPIA and VFA bosses state their concerns that the newly released EU Pharmaceutical Laws will furthe...

Read more
More clarity given on the proposed changes to comb...

The German government has released information regarding the 20% discounts to combination products e...

Read more
Germany – European joint assessment at deadlock ...

Germany's BPI and vfa advise that the implementation of the European Health Technology Assessment (E...

Read more
Developing scenario-based commercial assessments

Identification of current cost of oncology care treatment options.

Read more
Germany – Is digitisation the gateway to better ...

Digitisation is thought to contribute significant improvements in knowledge generation in drug devel...

Read more
Germany: Significant interest has been aroused by ...

From 2016, the Innovation Fund has served as an instrument of central health policy to promote new f...

Read more
Germany: Pros and cons of register-based randomise...

Study designs that combine explanatory and pragmatic aspects have recently been weighted up by autho...

Read more
Germany: Experts criticise the GKV’s financial s...

On 28th September there was a two-hour public hearing on the GKV Financial Stabilisation Act. There ...

Read more
Federal cabinet approves Lauterbachs draft GKV

One notable change from the last released updated bill was the removal of the solidarity levy of 2 b...

Read more
New pharmaceutical updated cost containment measur

This updated bill contains some similar measures to those proposed in March as well as some addition...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.